MitoChem Therapeutics

About:

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

Website: https://www.mitocheminc.com

Top Investors: South Carolina Research Authority, Foundation Fighting Blindness, SC Launch, Inc., Ichor Life Sciences

Description:

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative disease. It was founded by Craig Beeson and Bärbel Rohrer in Charleston, South Carolina.

Total Funding Amount:

$3.73M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Charleston, South Carolina, United States

Founded Date:

2011-01-01

Contact Email:

contact(AT)mitocheminc.com

Founders:

Bärbel Rohrer, Craig Beeson (1958-2019)

Number of Employees:

1-10

Last Funding Date:

2022-09-06

IPO Status:

Private

Industries: